semaglutide and eating disorders Disorder Patients Overuse GLP-1 Medications Ozempic Wegovy | Professor Erwin Loh posted on the topic What is an Eating Disorder?

JCI Insight (2020) 5(8)

No matter where youre starting or what your goals may be, youll find an empathetic and supportive partner in VIVE Medical Aesthetics

Her phenotype raised concern for rapid-onset obesity with hypoventilation, hypothalamic dysfunction, and autonomic dysregulation (ROHHAD), a potentially life-threatening disorder, although this was not definitively confirmed

G.VilsbollT

Another area of uncertainty involves side effects, as users' perceptions of symptoms such as nausea or fatigue may vary widely and may even be interpreted as markers of treatment efficacy

Saxenda (Liraglutide) Saxenda is a once-daily injectable weight loss drug that mimics the GLP-1 hormone, helping reduce hunger and calorie intake